Caisse de depot et placement du Quebec purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 20,650 shares of the company's stock, valued at approximately $9,974,000.
Several other hedge funds and other institutional investors have also bought and sold shares of ALAB. BlackRock Inc. purchased a new stake in shares of Astera Labs during the 2nd quarter valued at $6,609,581,000. Atreides Management LP grew its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. Amundi grew its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company's stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership bought a new position in Astera Labs during the fourth quarter valued at about $148,980,000. Finally, Goldman Sachs Group Inc. increased its holdings in Astera Labs by 189.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company's stock worth $218,419,000 after buying an additional 858,693 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.
Astera Labs Stock Down 4.8%
Shares of Astera Labs stock opened at $289.47 on Friday. The company's fifty day simple moving average is $342.38 and its two-hundred day simple moving average is $249.65. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market cap of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84.
Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the business posted $0.44 earnings per share. Astera Labs's revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.
Insider Activity
In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company's stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the completion of the transaction, the director owned 4,631 shares in the company, valued at $2,083,950. This represents a 66.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on ALAB shares. UBS Group reiterated a "neutral" rating and set a $425.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Stifel Nicolaus raised their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a "buy" rating in a research report on Wednesday, June 24th. Northland Securities upgraded Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 target price for the company in a research report on Monday, August 17th. Susquehanna upped their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a research note on Friday, July 31st. Finally, Jefferies Financial Group increased their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $340.53.
View Our Latest Analysis on Astera Labs
Astera Labs Company Profile
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.